Pages:
- A Sitemap for LambLawOffice.com
- About Firm
- Alabama: Medical Records Copying Charges Law / Statute
- Alaska: Medical Records Copying Charges Law / Statute
- Archive
- Arizona: Medical Records Copying Charges Law / Statute
- Arkansas: Medical Records Copying Charges Law / Statute
- Asbestos & Mesothelioma Overview
- Asbestos Claims: How Do I Get Legal Compensation?
- Attorney Profile: Thomas J. Lamb
- Benzene Cancer Resources
- Benzene Case Evaluation Form
- Benzene Cases Overview
- Benzene Diseases and Cancers
- Benzene Exposure and AML
- Benzene Exposure and MDS
- Benzene Exposure in Industries
- Benzene Exposures
- Benzene-Containing Products
- Benzene: Frequently Asked Questions
- Blog
- Breast Implant and Lymphoma: Resources
- Breast Implant and Lymphoma: Summary of Information
- Breast Implants and Lymphoma FAQs: About the Disease
- Breast Implants and Lymphoma FAQs: Prognosis
- Breast Implants and Lymphoma FAQs: Risk Factors
- Breast Implants and Lymphoma FAQs: Symptoms
- Breast Implants and Lymphoma FAQs: Treatment
- Breast Implants and Lymphoma: FDA Information
- Breast Implants and Lymphoma: Frequently Asked Questions
- Breast Implants and Lymphoma: The Disease
- Breast Implants Cancer Case Evaluation Form
- Breast Implants Cases Overview
- California: Medical Records Copying Charges Law / Statute
- Camp Lejeune Cancer Case Evaluation Form
- Camp Lejeune Cancer Claims and Legal Representation Information
- Camp Lejeune Justice Act: Cases, Claims, and Lawsuits Overview
- Camp Lejeune Lawsuit “Offset” Reduction to Legal Compensation: The Issue is If and How Much
- Camp Lejeune Legal Advertisements and Town Hall Events in North Carolina, Around the Country
- Camp Lejeune Parkinson Disease Risk is High, According to New 2023 Study
- Camp Lejeune Parkinson’s Disease Case Evaluation Form
- Camp Lejeune Parkinson’s Disease Cases and Legal Compensation
- Case Evaluation Explanation
- Case Evaluation Menu
- Class Action vs. Individual Lawsuits
- Clothing and Equipment with PFAS Causing Cancers in Firemen
- Colorado: Medical Records Copying Charges Law / Statute
- Connecticut: Medical Records Copying Charges Law / Statute
- Contact Us
- Current Drug Injury Litigations
- Delaware: Medical Records Copying Charges Law / Statute
- Directions to Our Office at Lumina Station
- Disclaimer and Copyright Notices
- District of Columbia: Medical Records Copying Charges Law / Statute
- Drug Injury Cases Overview
- ED Drugs (as well as BPH and PAH drugs)
- FDA Safety Alert about Philips Recall of CPAP Machines, BiPAP Devices, and Ventilators
- Florida: Medical Records Copying Charges Law / Statute
- Frequently Asked Questions
- General Case Evaluation Form
- GenX Cancer Case Evaluation Form
- GenX Resources For North Carolina Water Contamination
- GenX Water Contamination Cancers
- GenX Well Water Contamination in Fayetteville, North Carolina Area
- Georgia: Medical Records Copying Charges Law / Statute
- Hawaii: Medical Records Copying Charges Law / Statute
- Heartburn and Acid Reflux Drugs
- Hepatitis C Treatment Drugs – DAAs
- How Payment for Our Legal Services Works
- How to File a North Carolina Benzene Workers Compensation Claim
- Idaho: Medical Records Copying Charges Law / Statute
- Illinois: Medical Records Copying Charges Law / Statute
- Incretin Mimetic Drugs
- Indiana: Medical Records Copying Charges Law / Statute
- Iowa: Medical Records Copying Charges Law / Statute
- Kansas: Medical Records Copying Charges Law / Statute
- Kentucky: Medical Records Copying Charges Law / Statute
- Lamb Law Blog
- Learn More About How We Work
- Louisiana: Medical Records Copying Charges Law / Statute
- Maine: Medical Records Copying Charges Law / Statute
- Maryland: Medical Records Copying Charges Law / Statute
- Massachusetts: Medical Records Copying Charges Law / Statute
- Medical Records Copying Charges
- Medical Records Costs Update 2020: 21st Century Cures Act Amends “Patient Rates” Aspect of HITECH
- Mesothelioma and Asbestos Lawsuits
- Mesothelioma, Asbestos, and Legal Compensation: Basic Facts
- Michigan: Medical Records Copying Charges Law / Statute
- Minnesota: Medical Records Copying Charges Law / Statute
- Mississippi: Medical Records Copying Charges Law / Statute
- Missouri: Medical Records Copying Charges Law / Statute
- Montana: Medical Records Copying Charges Law / Statute
- Nebraska: Medical Records Copying Charges Law / Statute
- Nevada: Medical Records Copying Charges Law / Statute
- New Hampshire: Medical Records Copying Charges Law / Statute
- New Jersey: Medical Records Copying Charges Law / Statute
- New Mexico: Medical Records Copying Charges Law / Statute
- New York: Medical Records Copying Charges Law / Statute
- North Carolina: Medical Records Copying Charges Law / Statute
- North Dakota: Medical Records Copying Charges Law / Statute
- Ohio: Medical Records Copying Charges Law / Statute
- Oklahoma: Medical Records Copying Charges Law / Statute
- Oregon: Medical Records Copying Charges Law / Statute
- Our Investigation of Your Case
- Pennsylvania: Medical Records Copying Charges Law / Statute
- Philips Breathing Devices Case Evaluation Form
- Philips Breathing Devices Recall: Patient Injury Cases Overview
- Philips CPAP Machines Recall: FDA Warning Issued in July 2021
- Practice Areas
- Quick Contact Form
- Reporting Adverse Drug Reactions To The FDA MedWatch Program
- Resources: Legal, Medical, and More
- Rhode Island: Medical Records Copying Charges Law / Statute
- Sitemap for All Website Pages
- South Carolina: Medical Records Copying Charges Law / Statute
- South Dakota: Medical Records Copying Charges Law / Statute
- Tennessee: Medical Records Copying Charges Law / Statute
- Texas: Medical Records Copying Charges Law / Statute
- Thank You For Allowing Us To Review Your Possible Case
- Thank You for Completing Our Form
- The North Carolina Filing Deadline for Benzene Workers Comp Claims
- Thomas J. Lamb – Drug Injury, Asbestos Mesothelioma, Benzene Cancers
- Timeline: GenX Contamination of the Cape Fear River
- Timeline: GenX Study Results
- Type 2 Diabetes Drugs (DPP-4 Inhibitors)
- Type 2 Diabetes Drugs (SGLT-2 Inhibitors)
- Utah: Medical Records Copying Charges Law / Statute
- Vermont: Medical Records Copying Charges Law / Statute
- Virginia: Medical Records Copying Charges Law / Statute
- Washington: Medical Records Copying Charges Law / Statute
- We Will Not Pressure or Rush You to Sign Our Contract of Representation
- West Virginia: Medical Records Copying Charges Law / Statute
- What are Mesothelioma, Asbestos Lung Cancer, and Asbestosis?
- What is Asbestos?
- What We Know About GenX Water Contamination In North Carolina
- While We Are Working on Your Case
- Wisconsin: Medical Records Copying Charges Law / Statute
- Workers Exposed to Benzene
- Wyoming: Medical Records Copying Charges Law / Statute
- Your Drug Injury Case Review
Categories:
Authors:
- Legal Assistant (1)
- Thomas Lamb (669)
Monthly:
- September 2023
- August 2023
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
Recent Posts:
- Exhaled Breath May Predict Treatment Outcomes in Patients With Mesothelioma
- Study Questions Use of Aggressive Surgery in Early Mesothelioma
- Ozempic, Rybelsus, and Wegovy Use Might Cause Gastroparesis, Gastric Stasis, or Stomach Paralysis
- Ozempic Gastric Side Effects: Gastroparesis, Stomach Paralysis, Intestinal Blockages
- Feladilimab by GSK for Malignant Pleural Mesothelioma: Likelihood of Approval
- Syfovre Eye Injections Adverse Reactions Update August 2023
- Occupational exposure to cosmetic talc and mesothelioma in barbers, hairdressers, and cosmetologists: A systematic review of the epidemiology
- Tepezza-Related Hearing Problems Warning July 2023
- Malignant Pleural Mesothelioma (MPM) Presenting as Hydropneumothorax
- Syfovre-related Vision Loss Reported In Patients After Their First Injection
- Syfovre Retinal Vasculitis Cases Warning Letter July 2023
- Ozempic Safety Issues Update: July 2023 Edition
- Georgia-Pacific Is Litigation-Protected After Unit’s Bankruptcy
- Manufactured doubt and the EPA 2020 chrysotile asbestos risk assessment
- Ozempic Gallbladder Cases: Gallbladder Disease and Gallbladder Removal
- Trulicity Double-Dose Recall in 2021 is Still a Drug Safety Issue in 2023
- Merck reports positive data from malignant pleural mesothelioma trial
- Does the Presence of Asbestos-Containing Materials in Buildings Post-construction and Before Demolition Have an Impact on the Exposure to Occupants in Non-occupational Settings?
- Prolia Side Effect: Hypocalcemia in Patients on Dialysis
- Incidence of Malignant Pleural Mesothelioma Decreased in the United States During 2004 to 2019
- EzriCare Artificial Tears Case Reports Involving Vision Loss
- EPA Asks for More Public Input on Asbestos After ProPublica and Others Reveal New Information
- Breast Implant-Associated Lymphoma: PROFILE Registry; Update on Number of Cases
- A Gelatinous Pleural Effusion as a Diagnostic Clue
- Firefighter Protective Gear Made With Toxic Chemicals PFAS
- EzriCare and Delsam Products Recall: March 2023 Update
- Delsam Pharma Artificial Eye Ointment Recall February 2023
- Cancer patient asks court to end Georgia-Pacific asbestos bankruptcy
- EzriCare and Delsam Pharma’s Eye Drops Products Recall
- EzriCare Artificial Tears Eye Infections Warnings
- Pleural Mesothelioma: A Rapid Evolution of an Indolent Disease
- Avon Hit With $40 Million Verdict in California Talc Lawsuit
- Valtrex Side Effect: DRESS Skin Reaction, Can be Fatal
- Preoperative immunotherapy for mesothelioma shows favorable outcomes
- Benzene Facts: Learn About the Use of This Toxic Chemical, as well as Science, Medical, and Legal Aspects
- Tepezza Medical Articles About Drug Side Effects Focus on Hearing Issues
- Asbestos — two to three times more deadly than known
- Tepezza Hearing Loss, Other Tepezza Hearing Problems May be Irreversible and Permanent
- They inhaled asbestos for decades on the job. Now, workers break their silence
- FDA AdComm: Copiktra Risk-Benefit Profile No Longer Favorable as a Third-Line CLL/SLL Treatment
- Malignant Mesothelioma Mortality in Women — United States, 1999–2020
- Pembrolizumab / Lenvatinib Combo Shows Positive Clinical Activity in Recurrent Pleural Mesothelioma
- Gallbladder Side Effects Related to Byetta and Other GLP-1 Receptor Agonists
- The silent malignant mesothelioma epidemic: a call to action
- Camp Lejeune Claims for Veterans and Family Diagnosed With Cancers
- Breast Implants Lymphoma Cancer ALCL Case Numbers Increasing Rapidly in the US
- Galinpepimut-S Plus Nivolumab Extends Survival in Malignant Pleural Mesothelioma
- Second Surgery for Recurrent Malignant Pleural Mesothelioma after Multimodality Treatment: A Systematic Review
- Copiktra May Increase Risks of Death and Serious Side Effects
- A Case Report of Hypophosphatemia Leading to the Diagnosis of Mesothelioma
- Xalkori Side Effects: Children Suffering Ocular Toxicity and Severe Visual Loss
- Clinical-pathological characteristics and prognostic factors for malignant peritoneal mesothelioma in the elderly
- Ukoniq Death Risk is Reason for Ukoniq Drug Recall Says FDA
- Five PFAS Chemicals Added to List of Regional Screening and Removal Management Levels by the EPA
- J&J, 2-stepping through talc litigation, faces fresh claims it hid workers’ asbestos exposure
- Drug Injury Research: FDA Resources Online Available for Patients
- CDC: Mesothelioma Deaths Up Among Women
- Unexplained Pleural Effusion Leads to the Revelation of a Malignant Mesothelioma: A Case Report
- Pericardial Mesothelioma Presenting as Constrictive Pericarditis
- Ukoniq Withdrawn From Market Due to Increased Risk of Patient Deaths
- Health Canada Breast Implant Safety Review Shows High Risk of BIA-ALCL with Textured Implants
- Abemaciclib for Previously Treated Patients With p16ink4A-Deficient Mesothelioma
- MS Drugs Ocrevus and Gilenya Linked to Melanoma, Other Skin Cancers
- EPA rule would finally ban asbestos, carcinogen still in use
- Fosamax Lawsuits Dismissed Again by March 2022 Preemption Ruling
- April 2022 FDA Advisory Committee Meeting For Ukoniq Risk of Death
- Early Clinical Activity With CDK4/6 Inhibitor in Pretreated Mesothelioma
- Biphasic Peritoneal Mesothelioma: A Lethal Clinical Entity
- Beovu Label Change: Novartis Adds Information, Increases Safety Warnings in February 2022
- How People Can Report Adverse Drug Reactions to the FDA MedWatch Program
- An Overview of Benzene Exposure and its Adverse Health Effects
- First-line nivolumab plus ipilimumab versus chemotherapy in patients with unresectable malignant pleural mesothelioma: 3-year outcomes from CheckMate 743
- Xeljanz, Rinvoq, and Olumiant Safety Review by European Drug Regulator EMA
- Incidence, treatment and survival of malignant pleural and peritoneal mesothelioma: a population-based study
- Possible Ukoniq Drug Recall Due to Increased Risk of Death
- Malignant pleural mesothelioma patients’ experience by gender: findings from a cross-sectional UK-national questionnaire
- Xeljanz Safety Study Final Findings Presented in January 2022
- Malignant pleural mesothelioma patients’ experience by gender: findings from a cross-sectional UK-national questionnaire
- Asbestos Exposure and Malignant Mesothelioma in Construction Workers
- Beovu Drug Label Revised December 2021 Was Issued in Europe, But Not in the US
- Xeljanz Safety Alert for People Who Are (1) Older, (2) Current / Past Smokers, or (3) With Cardiovascular or Cancer Risk Factors
- EPA to Require Chemical Companies to Test Toxicity of Products
- Surgical Risk and Survival Associated With Less Invasive Surgery for Malignant Pleural Mesothelioma
- Immune Checkpoint Inhibitors Extend Survival for Mesothelioma
- Elmiron-associated Retinopathy and Other Elmiron Eye Problem Side Effects
- Beovu: Rates of Intraocular Inflammation and Retinal Vascular Occlusion
- Nivolumab plus ipilimumab confers sustained OS benefit in malignant pleural mesothelioma
- Cancers, Blood Clots, Heart Problems, and Deaths Associated with Xeljanz, Olumiant, and Rinvoq
- FDA Sets New Regulations for Breast Implant Manufacturers
- Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- Olumiant or Xeljanz: Is One of These JAK Inhibitor Drugs Safer?
- Imfinzi-Chemo Combo Improves Survival for Mesothelioma
- Certain Aerosol Antiperspirants Found to Contain High Levels of Benzene
- Philips Ventilators Recall: What The Company Knew and When, What It Did or Did Not Do, and More FDA Findings Released November 2021
- Nivolumab versus placebo in patients with relapsed malignant mesothelioma (CONFIRM): a multicentre, double-blind, randomised, phase 3 trial
- Immunotherapy combination maintains OS advantage in malignant pleural mesothelioma
- GenX Contamination May Be More Toxic Than EPA Initially Thought
- Gemcitabine with or without ramucirumab as second-line treatment for malignant pleural mesothelioma (RAMES): a randomised, double-blind, placebo-controlled, phase 2 trial
- Two Padcev-induced TEN / SJS Cases Where Patient Died From Their Padcev Side Effects
- Adding Atezolizumab to Neoadjuvant Cisplatin-Pemetrexed a Feasible Option in Malignant Pleural Mesothelioma